Hybrid Senior Director, Key Accounts Management Lead bei Cogentbiosciences
Cogentbiosciences · Waltham, Massachusetts, Vereinigte Staaten Von Amerika · Hybrid
- Optionales Büro in Waltham, Massachusetts
Who We Are
Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Top-line results from registration-directed trials in NonAdvanced SM, Advanced SM and GIST are expected in 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor. In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Our Team
The Sr. Director / Exec Director, National Accounts is a field-based position responsible for managing a team of Account Directors focused on gaining and maintaining broad coverage and access for Cogent’s products. This includes optimizing patient access within all assigned accounts, including GPO’s, regional payers, PBMs, targeted IDNs, MACs and state Medicaid agencies. This role is responsible for leading customer engagement with identified oncology and specialty accounts by developing strategic solutions and implementing account plans. They will focus on both new and expanding existing account relationships with a focus on c-suite, pharmacy leadership, clinical management and key decision makers. They will collaborate extensively with internal departments and functions including Marketing, Sales, and Sales Operations, Patient Services, Legal, and Compliance to implement product access initiatives.
